4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-063609
Options or other derivatives
- Chief Executive Officer acquired 350,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynch Casey Chief Executive Officer | 2020-12-11 | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | D: show line 1 in the form | ||
| Lynch Casey Chief Executive Officer | 2020-12-11 | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…